- Home
- ZONE vs SNSE Comparison
ZONE vs SNSE Comparison
Compare ZONE & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZONE
- SNSE
- Stock Information
- Founded
- ZONE 2022
- SNSE 2005
- Country
- ZONE United States
- SNSE United States
- Employees
- ZONE N/A
- SNSE N/A
- Industry
- ZONE
- SNSE Biotechnology: Pharmaceutical Preparations
- Sector
- ZONE
- SNSE Health Care
- Exchange
- ZONE NYSE
- SNSE Nasdaq
- Market Cap
- ZONE 10.9M
- SNSE 12.3M
- IPO Year
- ZONE 2024
- SNSE 2021
- Fundamental
- Price
- ZONE $2.18
- SNSE $0.45
- Analyst Decision
- ZONE
- SNSE Strong Buy
- Analyst Count
- ZONE 0
- SNSE 3
- Target Price
- ZONE N/A
- SNSE $4.33
- AVG Volume (30 Days)
- ZONE 88.3K
- SNSE 894.4K
- Earning Date
- ZONE 11-13-2024
- SNSE 11-14-2024
- Dividend Yield
- ZONE N/A
- SNSE N/A
- EPS Growth
- ZONE N/A
- SNSE N/A
- EPS
- ZONE N/A
- SNSE N/A
- Revenue
- ZONE $1,644,189.00
- SNSE N/A
- Revenue This Year
- ZONE N/A
- SNSE N/A
- Revenue Next Year
- ZONE N/A
- SNSE N/A
- P/E Ratio
- ZONE N/A
- SNSE N/A
- Revenue Growth
- ZONE N/A
- SNSE N/A
- 52 Week Low
- ZONE $1.21
- SNSE $0.38
- 52 Week High
- ZONE $4.24
- SNSE $1.94
- Technical
- Relative Strength Index (RSI)
- ZONE N/A
- SNSE 43.28
- Support Level
- ZONE N/A
- SNSE $0.52
- Resistance Level
- ZONE N/A
- SNSE $0.59
- Average True Range (ATR)
- ZONE 0.00
- SNSE 0.05
- MACD
- ZONE 0.00
- SNSE -0.01
- Stochastic Oscillator
- ZONE 0.00
- SNSE 8.72
About ZONE CLEANCORE SOLUTIONS INC
CleanCore Solutions Inc engages in the development and manufacturing of cleaning products that produce pure aqueous ozone for professional, industrial, or home use. The firm has a patented nanobubble technology using aqueous ozone that is effective in cleaning, sanitizing, and deodorizing surfaces and high-touch areas. The company offers products and solutions that are marketed for janitorial and sanitation, ice machine cleaning, laundry, and industrial industries. Its products are used in many types of environments including retail establishments, distribution centers, factories, warehouses, restaurants, schools and universities, airports, healthcare, food service, and commercial buildings such as offices, malls, and stores.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.